Bonjour,
Vous trouverez en accès libre cet article du Journal "PlLoS Medicine" :
Manslaughter by Fake Artesunate in Asia-Will Africa Be Next?
Paul N. Newton*, Rose McGready, Facundo Fernandez, Michael D. Green, Manuela
Sunjio, Carinne Bruneton, Souly Phanouvong, Pascal Millet, Christopher J. M.
Whitty, Ambrose O. Talisuna, Stephane Proux, Eva Maria Christophel, Grace
Malenga, Pratap Singhasivanon, Kalifa Bojang, Harparkash Kaur, Kevin Palmer,
Nicholas P. J. Day, Brian M. Greenwood, François Nosten, Nicholas J. White
http://medicine.plosjournals.org/perlserv?request=get-document&doi=10.1371/journal.pmed.0030197
"Falciparum malaria kills, and it particularly kills the rural poor.
Artemisinin derivatives, such as artesunate, are a vital component of
Plasmodium falciparum malaria treatment and control in the face of globally
increasing antimalarial drug resistance. Since 1998 a worsening epidemic of
sophisticated counterfeit "artesunate" tablets (containing no artesunate)
has plagued mainland Southeast Asia (see Figure S1). In some countries, most
of the available artesunate is fake [1-5].
Artemisinin derivatives are remarkably rapid in their antimalarial effects,
and they are very well tolerated. So where these medicines are available,
they are sought after. But as they are relatively expensive, a demand is
created for cheaper versions amongst the poorest and most vulnerable people,
upon whom the counterfeiters have preyed-with fatal results. [...]
Bonne lecture
Carinne Bruneton
Déléguée générale
Réseau Médicaments et Développement (ReMeD)
35 rue Daviel, 75 013 Paris
tél 33 1 53 80 20 20, fax 33 1 53 80 20 21
remed@remed.org ou c.bruneton@remed.org
web : http://www.remed.org